Market revenue in 2023 | USD 2,552.1 million |
Market revenue in 2030 | USD 2,464.9 million |
Growth rate | -0.5% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 79.35% in 2023. Horizon Databook has segmented the U.S. real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of cancer & chronic diseases and the growing need for their treatment are expected to fuel the demand in the market.
In addition, the growing prevalence of other chronic diseases, infectious diseases, and genetic disorders is increasing the demand for efficient diagnostic tests, driving market growth over the forecast period.
In addition, technological advancements is another major factor expected to facilitate market growth over the coming decade. For instance, in May 2023, Standard BioTools launched the X9 HighThroughput Genomics System.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into U.S. real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account